Lilly Drops $2B as Stock Dips

Lilly's stock is dipping 0.3% just as they're about to drop $2 billion on Kelonia Therapeutics. What's the deal with this timing? They're eyeing a stronger foothold in the $240 billion cancer-drug market. But why the market jitters now? Something's not adding up.

Apple's staring down a $38B fine in India. All because they won't hand over financials in an antitrust case. They claim Android's more dominant, but their market share's creeping up. Will they cough up the info by the May 21 deadline?

Broadcom is powering up 3.5 gigawatts for Anthropic with Google’s TPUs. Yeah, that’s massive. Everyone’s wondering if this means they’re finally breaking away from Nvidia. With tech giants going all-in on custom silicon, who’s next to join the independence club?